No Widgets found in the Sidebar
Vaxart to Speak at World Vaccine Congress Washington 2024 on April 3

Dr. Sean Tucker, Founder and Chief Scientific Officer of Vaxart, Inc., located in South San Francisco, California, will be presenting at the World Vaccine Congress Washington 2024 in Washington, D.C. on April 3, 2024. The presentation marks a recurring appearance for the company at the annual event in Washington, D.C.

During his presentation, Dr. Tucker will discuss the topic of “Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccination.” The presentation is scheduled for Wednesday, April 3, 2024 at 3:10 p.m. Eastern Time in Room 207A.

Vaxart is a clinical-stage biotechnology company that focuses on developing oral recombinant vaccines using its proprietary delivery platform. These vaccines are designed to be administered via pills, making them easy to store and ship without refrigeration while also eliminating the risk of needle-stick injuries. The company believes that its pill vaccine delivery platform is well-suited for delivering a range of vaccines, including oral versions of existing vaccines and new indications.

Currently, Vaxart’s development programs include pill vaccines for protection against coronavirus, norovirus, influenza as well as a therapeutic vaccine for human papillomavirus (HPV), the company’s first immune-oncology indication. In addition to these programs, Vaxart has filed various patent applications domestically and internationally to cover its proprietary technology and creations related to oral vaccination using adenovirus and TLR3 agonists.

For media relations inquiries please contact Mark Herr at Vaxart Inc., For investor relations inquiries please reach out to Andrew Blazier

By Samantha Jones

As a dedicated content writer at, I bring a unique blend of creativity and precision to my work. With a passion for storytelling and a keen eye for detail, I strive to craft engaging and informative articles that captivate our readers. From breaking news to thought-provoking features, I am committed to delivering content that resonates with our audience and keeps them coming back for more. Join me on this exciting journey as we explore the ever-evolving world of news and information together.

Leave a Reply